Biopsy Device Market Expanding Worldwide

Biopsy Device market is projected to grow due to the government initiatives to enhance availability of cancer diagnosis and treatment. Biopsy device market can be broadly classified into product segments such as guidance system, needles, guns, reagents & kits and others (brushes, curettes and punches etc.); by application such as medical diagnosis and scientific research; and by end users which are hospital, specialized oncology centre, diagnostic centre and research institutes.

Factors such as favourable reimbursement scenario in the U.S., demand for minimal invasive breast biopsy, and increasing preference for minimally-invasive biopsy procedures would contribute to the revenue growth of the biopsy device market over the forecast period.

Factors such as favourable reimbursement scenario in the U.S., demand for minimal invasive breast biopsy, and increasing preference for minimally-invasive biopsy procedures would contribute to the revenue growth of the biopsy device market over the forecast period.

Economic factors such as increasing discretionary funding for cancer research, cancer awareness programs by governments, and increasing global healthcare spending would contribute to the revenue growth of the biopsy device market over the forecast period.

Request Report Sample

The demand for biopsy devices has been significantly high in the U.S., Germany and China market in the recent years.

Asia pacific excluding Japan is also a lucrative market globally.  China is accounting for majority of revenue share.

By product, needles segment accounted for higher revenue share in global biopsy device market in comparison to the guidance system and guns market.

Biopsy Guidance system segment, is expected to record a robust growth in the forecast period.

The growth in guidance system can be attributed to the increasing trend towards advanced technology products.

Key players in the global biopsy devices market include Becton, Dickinson and Company , Argon Medical Inc., B. Braun Melsungen AG, Boston Scientific Inc., C. R. Bard, Inc., Hologic, Inc., Devicor Medical Products Inc. and others.

Economic factors such as increasing discretionary funding for cancer research, cancer awareness programs by governments, and increasing global healthcare spending would contribute to the revenue growth of the biopsy device market over the forecast period.

By application, medical diagnosis segment accounted for highest revenue share in biopsy device market as compared to scientific research segment.  This is expected to be closely followed by scientific research segment.

By end user, hospital segment accounts for higher consumption of biopsy devices as compared to other end user segments such as specialized oncology centre, diagnostic centre and research institutes.

The strong growth in hospital segment can be attributed to increasing population preference for hospitals which can provide better assistance on increasing use for monitoring the disease and increasing incidences of breast cancers leading to breast biopsies.

In addition to Asia Pacific excluding Japan, demand for biopsy devices has been significantly growing in Middle East and Africa, and Latin America.

Revenues in APEJ are anticipated to grow. Breast biopsy, which in turn contribute to the growth of the global biopsy device market.

More Info of Impact Covid19 

Only $1/click

Submit Your Ad Here

Steve Jojn

Trends Market Research is one of the leading digital services provider and a result-oriented company based in U.K.. We are a team of enthusiastic-driven individuals with top notch skills in SEO , Market research. Trends Market Research is a one stop shop to all your business needs. We help you thrive and succeed. We provide research solution.
http://www.trendsmarketresearch.com

Leave a Reply